These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6427271)

  • 1. Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion.
    Schürmeyer T; Knuth UA; Freischem CW; Sandow J; Akhtar FB; Nieschlag E
    J Clin Endocrinol Metab; 1984 Jul; 59(1):19-24. PubMed ID: 6427271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility.
    Michel E; Bents H; Akhtar FB; Hönigl W; Knuth UA; Sandow J; Nieschlag E
    Clin Endocrinol (Oxf); 1985 Dec; 23(6):663-75. PubMed ID: 3938352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
    Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
    J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of primate testicular function by GnRH analogues.
    Weinbauer GF; Nieschlag E
    Med Biol; 1986; 63(5-6):210-7. PubMed ID: 3084885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps.
    Akhtar FB; Marshall GR; Wickings EJ; Nieschlag E
    J Clin Endocrinol Metab; 1983 Mar; 56(3):534-40. PubMed ID: 6401760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a potent LHRH-agonist on the pituitary gonadal axis with and without testosterone substitution.
    Frick J; Aulitzky W
    Urol Res; 1986; 14(5):261-4. PubMed ID: 3099445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The function of the hypophyseo-gonadal system in hamadryas baboons during the tonic infusion of a luliberin agonist--buserelin].
    Goncharova ND; Goncharov NP
    Probl Endokrinol (Mosk); 1989; 35(5):68-72. PubMed ID: 2511570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of neonatal activation of the pituitary-testicular axis: effect on peripubertal luteinizing hormone and testosterone secretion and on testicular development in male monkeys.
    Mann DR; Gould KG; Collins DC; Wallen K
    J Clin Endocrinol Metab; 1989 Mar; 68(3):600-7. PubMed ID: 2493038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of suppression of pituitary-testicular function during fetal life with a GnRH agonist on reproductive development in ram lambs during the first 28 weeks of life.
    Thomas GB; McNeilly AS; Brooks AN
    J Reprod Fertil Suppl; 1995; 49():533-7. PubMed ID: 7623344
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of neonatal activation of the pituitary-testicular axis with continuous administration of a gonadotropin-releasing hormone agonist in male rhesus monkeys.
    Mann DR; Davis-DaSilva M; Wallen K; Coan P; Evans DE; Collins DC
    J Clin Endocrinol Metab; 1984 Aug; 59(2):207-11. PubMed ID: 6376528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of continuous treatment of stallions with high levels of a potent GnRH analogue.
    Boyle MS; Skidmore J; Zhang J; Cox JE
    J Reprod Fertil Suppl; 1991; 44():169-82. PubMed ID: 1795259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies.
    Ehrmann DA; Rosenfield RL; Cuttler L; Burstein S; Cara JF; Levitsky LL
    J Clin Endocrinol Metab; 1989 Nov; 69(5):963-7. PubMed ID: 2529266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.